Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 4
2013 2
2014 2
2015 1
2016 1
2017 2
2021 4
2022 9
2023 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Benefits of Gut Microbiota Reconstitution by Beta 1,3-1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases.
Raghavan K, Dedeepiya VD, Yamamoto N, Ikewaki N, Sonoda T, Iwasaki M, Kandaswamy RS, Senthilkumar R, Preethy S, Abraham SJK. Raghavan K, et al. Among authors: dedeepiya vd. J Alzheimers Dis. 2023;94(s1):S241-S252. doi: 10.3233/JAD-220388. J Alzheimers Dis. 2023. PMID: 36093695 Free PMC article. Clinical Trial.
β‑glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B‑VACCIEN) in specific immunocompromised populations (Review).
Ikewaki N, Dedeepiya VD, Raghavan K, Rao KS, Vaddi S, Osawa H, Kisaka T, Kurosawa G, Srinivasan S, Kumar SRB, Senthilkumar R, Iwasaki M, Preethy S, Abraham SJK. Ikewaki N, et al. Among authors: dedeepiya vd. Oncol Rep. 2022 Jan;47(1):14. doi: 10.3892/or.2021.8225. Epub 2021 Nov 15. Oncol Rep. 2022. PMID: 34779494 Review.
Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis.
Preethy S, Raghavan K, Dedeepiya VD, Surya Prakash V, Ikewaki N, Ikeue Y, Nagataki M, Iwasaki M, Senthilkumar R, Abraham SJK. Preethy S, et al. Among authors: dedeepiya vd. Front Immunol. 2022 Jun 27;13:870632. doi: 10.3389/fimmu.2022.870632. eCollection 2022. Front Immunol. 2022. PMID: 35833122 Free PMC article. Review.
Corrigendum to "Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study" [IBRO Neurosci. Rep. 15 (2023), pp. 90-99].
Raghavan K, Dedeepiya VD, Srinivasan S, Pushkala S, Bharatidasan SS, Ikewaki N, Iwasaki M, Senthilkumar R, Preethy S, Abraham SJK. Raghavan K, et al. Among authors: dedeepiya vd. IBRO Neurosci Rep. 2023 Aug 9;15:149-150. doi: 10.1016/j.ibneur.2023.08.001. eCollection 2023 Dec. IBRO Neurosci Rep. 2023. PMID: 37593322 Free PMC article. No abstract available.
Engraftment and Proliferation of Thermoreversible-Gelation-Polymer-Encapsulated Human Corneal Limbal-Stem-Cells on Ocular Surface of a Cadaver Cornea.
Senthilkumar R, Yoshioka H, Katoh S, Iwasaki M, Surya Prakash V, Balamurugan M, Dedeepiya VD, Preethy S, Abraham SJK. Senthilkumar R, et al. Among authors: dedeepiya vd. Curr Eye Res. 2023 Jun;48(6):564-572. doi: 10.1080/02713683.2023.2180039. Epub 2023 Feb 28. Curr Eye Res. 2023. PMID: 36852699 Free article.
Efficacy of N-163 beta-glucan in beneficially improving biomarkers of relevance to muscle function in patients with muscular dystrophies in a pilot clinical study.
Raghavan K, Sivakumar T, Ichiyama K, Yamamoto N, Balamurugan M, Dedeepiya VD, Senthilkumar R, Preethy S, Abraham SJ. Raghavan K, et al. Among authors: dedeepiya vd. Acta Myol. 2023 Dec 20;42(4):129-134. doi: 10.36185/2532-1900-312. eCollection 2023. Acta Myol. 2023. PMID: 38406382 Free PMC article.
29 results